SLC6A3 and diphtheria: Horse serum therapy, commonly known as diphtheria antitoxin (DAT), was introduced in 1890, when Behring and Kitasato proved that passive immunisation with anti-tetanus and anti-diphtheria sera could protect against these bacterial diseases [105].